Related references
Note: Only part of the references are listed.CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer
Xiaoye Sang et al.
CANCERS (2022)
Disruption of mitochondrial redox homeostasis as a mechanism of antimony-induced reactive oxygen species and cytotoxicity
Liling Su et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2022)
Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion
Byong-Sop Song et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3-mediated deacetylation of PYCR1
Qi Wang et al.
JOURNAL OF MOLECULAR HISTOLOGY (2022)
Mitochondrial Dysfunction in Podocytes Caused by CRIF1 Deficiency Leads to Progressive Albuminuria and Glomerular Sclerosis in Mice
Ki Ryang Na et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma
Hulin Chang et al.
CELL DEATH & DISEASE (2020)
Small interfering RNA for cancer treatment: overcoming hurdles in delivery
Nitin Bharat Charbe et al.
ACTA PHARMACEUTICA SINICA B (2020)
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
Ghanbar Mahmoodi Chalbatani et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
Christopher Nguyen et al.
CANCERS (2019)
CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma
Qian Ran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation
Henning Karlsson et al.
Oncotarget (2019)
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Muhamad Noor Alfarizal Kamarudin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Role of mitochondrial dysfunction in the pathophysiology of DNA repair disorders
Mateus Prates Mori et al.
CELL BIOLOGY INTERNATIONAL (2018)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
Amruta P. Nayak et al.
CANCERS (2018)
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
Cristian Scatena et al.
FRONTIERS IN ONCOLOGY (2018)
Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation
Xiaoyun Tang et al.
MOLECULAR CANCER (2017)
The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy
Yaojie Fu et al.
ONCOTARGET (2017)
Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies
Neda Shajari et al.
CURRENT DRUG DELIVERY (2017)
CR6-Interacting Factor 1 Deficiency Impairs Vascular Function by Inhibiting the Sirt1-Endothelial Nitric Oxide Synthase Pathway
Harsha Nagar et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer
Chia-Ing Jan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer
Ying-Hui Ko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents
N. Yadav et al.
CELL DEATH & DISEASE (2015)
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
Laura Schoeckel et al.
CANCER & METABOLISM (2015)
Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells
Hairong Song et al.
PLOS ONE (2014)
Crif1 Deficiency Reduces Adipose OXPHOS Capacity and Triggers Inflammation and Insulin Resistance in Mice
Min Jeong Ryu et al.
PLOS GENETICS (2013)
BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
Peter Ellinghaus et al.
CANCER MEDICINE (2013)
Mitochondrial Regulation of Cell Cycle and Proliferation
Valeria Gabriela Antico Arciuch et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
CRIF1 Is Essential for the Synthesis and Insertion of Oxidative Phosphorylation Polypeptides in the Mammalian Mitochondrial Membrane
Soung Jung Kim et al.
CELL METABOLISM (2012)
Metformin: A Therapeutic Opportunity in Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2010)
Share Paper
